* Program expected to commence in Q4 2026 and establish a roadmap for larger-scale production in 2027LOS ANGELES, CA / ACCESS Newswire / September 8, 2026 / Today, Inc. (NASDAQ:EXOZ) ("") - a pioneer of AI-enhanced enzymes that transform abundant feedstock into valuable nutraceuticals and novel medicines - announced that it has entered into an agreement with Curia Global, Inc.
Management to Host Conference Call Today at 4:30PM Eastern Monrovia, CA, April 02, 2025 (GLOBE NEWSWIRE) -- Today, eXoZymes Inc. (NASDAQ: EXOZ)...
Expanded leadership team as eXoZymes ramps up commercial growth Damien Perriman brings more than two decades of experience in successfully developing...
This is the newest page. Registered accounts read further back.